Are you Dr. Abdi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 305-243-8470
Summary
- Dr. Salahadin Abdi, MD is a board certified anesthesiologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Georgia.
Certifications & Licensure
AZ State Medical License 2022 - 2026
GA State Medical License 2023 - 2026
LA State Medical License 2022 - 2026
TN State Medical License 2022 - 2026
TX State Medical License 1997 - 2026
WA State Medical License 2022 - 2026
AL State Medical License 2023 - 2025
American Board of Anesthesiology Anesthesiology- Join now to see all
Publications & Presentations
PubMed
- Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, t...Honorio T Benzon, David Anthony Provenzano, Ameet Nagpal, Dmitri Souza, Maxim S Eckmann
Regional Anesthesia and Pain Medicine. 2025-03-12 - Use of corticosteroids for adult chronic pain interventions: sympathetic and peripheral nerve blocks, trigger point injections - guidelines from the American Society o...Honorio T Benzon, Dalia Elmofty, Hariharan Shankar, Maunak Rana, Andrea L Chadwick
Regional Anesthesia and Pain Medicine. 2025-03-12 - A unique utilization of scrambler therapy for bilateral neuropathic corneal pain: a case report.Peter D Vu, Salahadin Abdi
Pain Management. 2025-03-01
Press Mentions
Peripheral Neuropathy: Causes, Symptoms and TreatmentsAugust 24th, 2023- The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot StudyMay 1st, 2023
Cancer Pain Management Brings Patients ReliefNovember 15th, 2017- Join now to see all
Grant Support
- Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral NeuropathyPURE GREEN PHARMACEUTICALS, INC.2023–2025
- Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral NeuropathyPURE GREEN PHARMACEUTICALS, INC.2023–2025
- Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot studyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2025
